Product nameMouse IgG1, Kappa Monoclonal (NCG01) - Isotype Control - BSA and Azide Free
See all Mouse isotype controls
SpecificityThis mouse monoclonal IgG1 was produced against a synthetic hapten, which is normally not present in humans or animals. Therefore, this mouse IgG1 does not react with any antigen of human or animal cells.
Tested applicationsSuitable for: WB, IP, ELISA, IHC-P, IHC-Fr, GSA, Flow Cyt, ICC/IFmore details
Species reactivityDoes not react with any antigen of human or animal cells.
Abcam is committed to meeting high quality standards of ethical manufacturing and has decided to discontinue this product by June 2020 as it has been generated by the ascites method. We are sorry for any inconvenience this may cause. We suggest ab18447 as a possible replacement.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Storage bufferpH: 7.40
Constituent: 0.0268% PBS
Concentration information loading...
Purification notesPurified from ascites fluid by Protein G chromatography.
Light chain typekappa
- Mouse Isotype Control
Our Abpromise guarantee covers the use of ab81032 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration.|
|IP||Use at an assay dependent concentration.|
|ELISA||Use at an assay dependent concentration.|
|IHC-P||Use at an assay dependent concentration.|
|IHC-Fr||Use at an assay dependent concentration.|
|GSA||Use at an assay dependent concentration.|
|Flow Cyt||Use at an assay dependent concentration.|
|ICC/IF||Use at an assay dependent concentration.|
|EMSA||Use at an assay dependent concentration.|
This product has been referenced in:
- Shah M et al. Recurrent glucose deprivation leads to the preferential use of lactate by neurons in the ventromedial hypothalamus. Am J Physiol Endocrinol Metab 316:E948-E955 (2019). Read more (PubMed: 30888861) »
- Faralli JA et al. Effect of avß3 Integrin Expression and Activity on Intraocular Pressure. Invest Ophthalmol Vis Sci 60:1776-1788 (2019). Read more (PubMed: 31022732) »